intrinsically lead to "replication factories" with DNA moving toward a dual replisome. On the other hand, the twin pump and ploughshare mechanisms could make repairing intrastrand crosslinks difficult given that the helicase complex would presumably arrest with the crosslink in the Mcm2-7 central channel. Only a better understanding of the replication initiation process will distinguish between these models and reveal the mechanism of Mcm2-7 action.
To become fully transformed, primary human cells need to bypass several cellular failsafe mechanisms that normally keep cellular growth in check. In addition, transformed cells can become selfsufficient by producing their own growth signals. Activating mutations in protooncogenes are a frequent path to cellular neoplastic transformation, and several reports have described the dependence of cancer cells on the oncogene even after transformation (Weinstein and Joe, 2008) . However, in this issue of Cell, Struhl and colleagues (Iliopoulos et al., 2009) report that transient induction of the Src oncogene in nontransformed human mammary epithelial cells results in production of the cytokine interleukin-6 (IL-6), which drives-and maintains-cells in a transformed state. This is mediated by a positive feedback loop involving IL-6, NF-κB, the let-7 micro-RNA (miRNA), and its regulator, LIN28B, resulting in a "snowball" effect.
NF-κB is a transcription factor that can induce the expression of IL-6, a cytokine that plays a crucial role in the immune response and inflammation. LIN28B is a stem cell factor and RNA binding protein that inhibits processing of the let-7 miRNA (Viswanathan et al., 2008) . Changes in let-7 expression have been associated with tumorigenesis. Although links between inflammation and cancer have been suggested, a link between NF-κB and let-7 has not been reported so far. However, the new work links all of these four players and demonstrates that they cooperate to maintain cellular transformation in response to transient oncogene activation (Iliopoulos et al., 2009) .
How transient is the oncogenic signal and how does it work? Iliopoulos et al. expressed a tamoxifen-inducible estrogen receptor-Src (ER-Src) fusion protein in nontransformed human mammary epithelial cells. They show that a 5 min treatment with tamoxifen is sufficient to drive the cells into the transformed state. Next, they provide evidence that this transient treatment induces expression of the inflammatory cytokine IL-6 in an NF-κB-dependent manner. Specifically, they show that Src activates NF-κB, which directly activates the transcription of LIN28B. Indeed, the expression of the mature let-7 miRNA rapidly decreases in response to Src activation, through induction of LIN28B. As a result, IL-6, a direct target of let-7, is derepressed, causing cellular transformation through STAT3, a transcriptional activator that is phosphorylated and activated in response to IL-6 signaling. A positive feedback loop is generated through IL-6, the expression of which is induced by NF-κB, but IL-6 can itself activate NF-κB ( Figure 1A ). This loop explains why the transformed state is maintained even after Src expression is shut off. Confirming this model, the authors report that During neoplastic transformation, cells can promote their own growth by activating proto-oncogenes. Reporting in Cell, Iliopoulos et al. (2009) now show that in certain cell types, a transient oncogenic signal is sufficient to induce neoplastic transformation and to maintain it through a positive feedback loop driven by the inflammatory cytokine interleukin-6.
Transformation Locked in a Loop
Cell 139, November 13, 2009 ©2009 Elsevier Inc. 655 inhibition of any of the components of the feedback loop reverses the transformed phenotype. The authors provide evidence that their findings may be relevant to some human cancers. In both normal and cancer cells (derived from breast, prostate, and hepatocellular tissues), the authors find a negative correlation between the expression of the let-7 miRNA and that of IL-6. In normal cells, let-7 levels are high and IL-6 levels are low, whereas in cancer cells let-7 levels are low and IL-6 levels are high. These observations suggest that the feedback loop involving IL-6 and let-7 may be active in these cancer cells. Furthermore, interference with any component of the inflammatory feedback loop inhibited the tumorigenicity of several human cancer cell lines. However, despite this striking negative correlation in certain human cancers, in vivo tumor models will be needed to prove a causal role for this regulatory circuit in driving tumorigenesis. Intriguingly, mice lacking IL-6 are more resistant to the formation of tumors driven by the Ras oncogene and to developing tumors of the colon associated with inflammatory colitis than normal mice, suggesting causality (Ancrile et al., 2007; Grivennikov et al., 2009) . Future experiments should address whether the IL-6/NF-κB/LIN28B/let-7 loop is involved in the formation of tumors in these animal models.
Many reports have shown that IL-6-mediated inflammation and cancer are linked. However, both tumor-suppressive and tumor-promoting activities have been ascribed to IL-6. In accordance with the observations of Iliopoulos et al. suggesting a tumor-promoting role for IL-6, a recent study showed that IL-6 expression, induced by the Ras V12 oncogene, is required for tumor growth of human kidney cells in vivo (Ancrile et al., 2007) . On the other hand, oncogeneinduced IL-6 upregulation in primary human fibroblasts results in senescence (Kuilman et al., 2008) . This antiproliferative response is mediated, at least in part, by the induction of the cyclindependent kinase inhibitor p15 INK4B (Figure 1B) . How can these results be reconciled with the findings of Iliopoulos and colleagues? Remarkably, the spontaneous immortalization of the mammary epithelial cells used by Iliopoulos et al. is associated with a deletion on chromosome 9p21. This deletion includes part of the INK4/ARF locus, such that these cells lack the genes encoding the cyclindependent kinase inhibitors p15 INK4B and p16
INK4A (Cowell et al., 2005) . This raises the exciting possibility that the type of IL-6 response that is induced after oncogene activation depends on the status of the INK4/ARF locus. Consistent with this hypothesis, the human kidney cells used in the study of Ancrile et al. in (Voorhoeve and Agami, 2003) was not sufficient to maintain transformation, perhaps indicating that the IL-6 response might be cell-type dependent.
Iliopoulos et al. made another interesting observation. They report that their positive feedback loop is required for the self-renewing capacity of tumorinitiating cells, so-called cancer stem cells ( Figure 1C) . A small proportion of the mammary epithelial cells expressing the ER-Src fusion protein that were transiently treated with tamoxifen acquired properties of cancer stem cells, such as self-renewal capacity. The inflammatory loop was more active in this population compared to cells that did not self-renew. When the authors blocked the function of several components in the feedback circuit, they saw a decrease in the selfrenewal capacity of the cancer stem cells. This is not the first time a transient signal was found to induce stem cell formation. For example, it is well established that reprogramming of adult fibroblasts back to a stem cell-like state can occur after transient expression of the reprogramming factors OCT4, SOX2, c-MYC, and KLF4 (Soldner et al., 2009 ), pointing to the involvement of a positive feedback loop. The results of Iliopoulos et al. suggest that the IL-6/NF-κB/LIN28B/ let-7 loop could also be at work in the reprogramming of fibroblasts. Given that LIN28B can also be used as a reprogramming factor, it is tempting to speculate about the involvement of the positive feedback loop identified by Iliopoulos et al. in stem cell maintenance. Intriguingly, the INK4/ARF locus serves as a barrier to efficient reprogramming (Li et al., 2009) , again implying that this locus plays an important role in the effects observed by Iliopoulos et al. The Iliopoulos et al. study shows that a transient oncogenic trigger can lead to cellular transformation. This is mediated through an inflammatory signal and subsequent activation of a positive feedback loop containing IL-6, NF-κB, let-7, and LIN28B. From a therapeutic point of view, this study and others raise the possibility that tumors with this overactive positive feedback loop-LIN28B HIGH / Let-7 LOW /IL-6 HIGH -may be eradicated efficiently by interference with this loop, which also may inhibit the growth of cancer stem cells.
